Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Nirvana is a London-based start-up brewery looking to create a range of low/non-alcoholic craft beers, creating a viable, flavoursome option for those that enjoy quality beer but cannot or choose not to consume alcohol.
days to go:
Expired
investment:
£974
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go:
Expired
investment:
£136,827
Oru Space seamlessly blends coworking, wellbeing, and food, fostering connection and regenerative culture through a network of interconnected decision-making processes. Their ecosystem encompasses inclusive communities, dynamic spaces, and sustainability-driven actions, aiming to rejuvenate high streets, launch social initiatives, and prioritize well-being while achieving both economic success and environmental health.
days to go:
Expired
investment:
£455,364
Better Nature Tempeh, a nutritious plant-based food, with over 300 years of history in Indonesian cuisine, is their specialty. Already available in major retailers and featured in meal services like allplants, Pure, and Mindful Chef, we aim to transform the meat-free market. People love their tempeh for its health benefits; 1 of your 5 a day, 100% natural ingredients, low carbon footprint, great taste, and easy cooking. Their mission is help people live healthier lives.
days to go:
Expired
investment:
£494,410
Vita Mojo is an award winning food technology company, providing affordable meals tailored specifically to the customer. The food is personal and transparent as to what goes into each dish and how it was prepared. All ingredients are picked to suit your own tastes and needs, and can be personalised to increase your protein or decrease your calories as required.
days to go:
Expired
investment:
£3,200,080
Perfect World makes delicious, healthy vitamin-fortified plant-based ice cream with no added sugars. Its mission is to make ice creams that create a trend towards healthier eating. The company has spread to 228 stores under the Jumbo Supermarket listing, Netherlands. It has also signed a Non-Disclosure Agreement (NDA) with a US factory for testing and hopes to establish itself there as well. For its innovation, Perfect World won the Best of Health Awards in 2018. It also received national press coverage and won a host of other awards including The Daily Mail Healthy Ice Cream Round Award competing against 9 other brands in 2019. The company will use the funds to rapidly build stock levels and focus widespread, locally targeted social media targeting in the UK, introduce new flavours which have already gone through factory scaling and sample production in the Netherlands and Nordic countries, and further its EU and USA distribution and production opportunities.
days to go:
Expired
investment:
£119,412
